EP0928202A4 - Administration non invasive de vecteur viraux aav - Google Patents

Administration non invasive de vecteur viraux aav

Info

Publication number
EP0928202A4
EP0928202A4 EP97909861A EP97909861A EP0928202A4 EP 0928202 A4 EP0928202 A4 EP 0928202A4 EP 97909861 A EP97909861 A EP 97909861A EP 97909861 A EP97909861 A EP 97909861A EP 0928202 A4 EP0928202 A4 EP 0928202A4
Authority
EP
European Patent Office
Prior art keywords
adeno
viral vectors
associated viral
invasive administration
invasive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97909861A
Other languages
German (de)
English (en)
Other versions
EP0928202A1 (fr
Inventor
Richard Snyder
Olivier Danos
James Mcarthur
Richard Mulligan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Genesys Inc
Original Assignee
Cell Genesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Genesys Inc filed Critical Cell Genesys Inc
Publication of EP0928202A1 publication Critical patent/EP0928202A1/fr
Publication of EP0928202A4 publication Critical patent/EP0928202A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP97909861A 1996-09-25 1997-09-25 Administration non invasive de vecteur viraux aav Withdrawn EP0928202A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2663896P 1996-09-25 1996-09-25
US2663P 1996-09-25
PCT/US1997/016929 WO1998013070A1 (fr) 1996-09-25 1997-09-25 Administration non invasive de vecteur viraux aav

Publications (2)

Publication Number Publication Date
EP0928202A1 EP0928202A1 (fr) 1999-07-14
EP0928202A4 true EP0928202A4 (fr) 2001-09-05

Family

ID=21832986

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97909861A Withdrawn EP0928202A4 (fr) 1996-09-25 1997-09-25 Administration non invasive de vecteur viraux aav

Country Status (6)

Country Link
EP (1) EP0928202A4 (fr)
JP (1) JP2001501819A (fr)
KR (1) KR20000048623A (fr)
AU (1) AU743335B2 (fr)
CA (1) CA2266619A1 (fr)
WO (1) WO1998013070A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1005376B1 (fr) * 1997-03-14 2010-11-03 The Children's Hospital of Philadelphia Compositions utilisees en therapie genique dans le traitement de l'hemophilie
EP1279740A1 (fr) * 2001-07-26 2003-01-29 Vrije Universiteit Brussel Vector recombinant dérivé d'un virus-adéno-associé pour l'utilisation thérapie génique
KR20030068337A (ko) * 2002-02-15 2003-08-21 사회복지법인삼성생명공익재단(삼성서울병원) 유전자치료용 진핵발현벡터
KR20030070702A (ko) * 2002-02-26 2003-09-02 사회복지법인삼성생명공익재단(삼성서울병원) 전기적 자극을 이용한 ｄｎａ 전달방법 및 이를 이용한 에리스로포이에틴 발현 방법
EP4063510A1 (fr) * 2018-11-07 2022-09-28 Akouos, Inc. Utilisation de vecteurs viraux adéno-associés pour corriger des défauts de gène/exprimer des protéines dans des cellules ciliées et de soutien dans l'oreille interne
CN115161289B (zh) * 2022-03-14 2023-12-05 东南大学 一种用于炎症性疾病治疗的重组腺相关病毒及其构建方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020671A1 (fr) * 1994-01-28 1995-08-03 Rhone-Poulenc Rorer S.A. Procede de preparation de virus adeno-associes (aav) recombinants et utilisations
WO1995027494A1 (fr) * 1994-04-11 1995-10-19 Sloan-Kettering Institute For Cancer Research VECTEURS DE VIRUS HERPES DEFECTIFS ET DE VIRUS ADENO-ASSOCIES DEFECTIFS COMPORTANT p53 ET DESTINES AU TRAITEMENT DU CANCER

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) * 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) * 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020671A1 (fr) * 1994-01-28 1995-08-03 Rhone-Poulenc Rorer S.A. Procede de preparation de virus adeno-associes (aav) recombinants et utilisations
WO1995027494A1 (fr) * 1994-04-11 1995-10-19 Sloan-Kettering Institute For Cancer Research VECTEURS DE VIRUS HERPES DEFECTIFS ET DE VIRUS ADENO-ASSOCIES DEFECTIFS COMPORTANT p53 ET DESTINES AU TRAITEMENT DU CANCER

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9813070A1 *

Also Published As

Publication number Publication date
WO1998013070A1 (fr) 1998-04-02
AU4736797A (en) 1998-04-17
AU743335B2 (en) 2002-01-24
KR20000048623A (ko) 2000-07-25
CA2266619A1 (fr) 1998-04-02
JP2001501819A (ja) 2001-02-13
EP0928202A1 (fr) 1999-07-14

Similar Documents

Publication Publication Date Title
GB9806154D0 (en) Therapeutic formulations
HUP9903541A3 (en) Nasal administration of desmopressin
IL122349A0 (en) Adeno-associated viral vectors
EP1037669A4 (fr) Emploi therapeutique de vecteurs lentiviraux
EP0928202A4 (fr) Administration non invasive de vecteur viraux aav
GB2309887B (en) Structure of percolator
CY2590B2 (en) Preparation of 1-butyl-4-piperidinylmethylamine
GB9620777D0 (en) Therapeutic use
ZA986047B (en) 6-pyrrolidin-2-ylpyrindines their preparation and their therapeutic application
IL124387A0 (en) Preparation of 5-Methyleneoxazolines
GB2329384B (en) Preparation of 1-chloro-1-cyclopropylethene
TW315720U (en) Structure of treadmill also having the resupination function of human body
TW354896U (en) Improvement of bateering massager bat
TW308020U (en) Improved structure of chair
TW301219U (en) Improved structure of massage chair
TW325694U (en) Improved structure of physical therapeutic belt
TW308016U (en) Improved structure of chair
TW320885U (en) Flexible structure of leisure chair
TW318336U (en) Structure of embossed-type button
TW322747U (en) Structure of combination chair (2)
TW317138U (en) Improved structure of leisure chair
TW320018U (en) Improved structure of leisure chair
TW322744U (en) Structure of combination chair
TW325705U (en) Improved structure of flexible pad
TW301168U (en) Improved chair crutch structure

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990324

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20010725

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20021106

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030517